PSR Orphan Experts (now Ergomed)

We’ve moved! PSR Orphan Experts is now Ergomed. To stay updated on future news, please follow us on the Ergomed Twitter page at

[PSR Orphan Experts (now Ergomed) @PSRorphan]

We’ve moved! PSR Orphan Experts is now Ergomed. To stay updated on future news, please follow us on the Ergomed Twitter page at https://t.co/o3TdMuMbFt

For more information, please visit: https://t.co/D6cmHs1I03

#Ergomed #GlobalCRO #clinicaltrial #oncology #RareDiseases

[Ergomed @ErgomedPLC]

Didn't have the chance to listen to our latest rare disease-focused webinar? Watch now as our expert speakers discuss the topic "Early Involvement of Patients in Pharmaceutical Research and Development for Rare Diseases. “

Now available: https://t.co/ZOpVKYtceD

[Ergomed @ErgomedPLC]

Do not miss our latest webinar next week on March 16th, where our expert speakers will discuss the topic "Early Involvement of Patients in Pharmaceutical Research and Development for Rare Diseases."

To register: https://t.co/E2CVUY9Ezl
For more info: https://t.co/XFH86z6Hi2

[PSR Orphan Experts (now Ergomed) @PSRorphan]

Today is a day to celebrate women's achievements.
We are proud to state that the Ergomed Group has 76% of its workforce as women. 73% of our line managers are women.
Thank you for helping us thrive with your hard work and commitment.

Happy Women's Day!

#IWD2021

[Ergomed @ErgomedPLC]

REGISTRATION NOW OPEN: Titled "Early Involvement of Patients in Pharmaceutical Research and Development for Rare Diseases", this free webinar will occur on 16 March 2021.

To register: https://t.co/E2CVUY9Ezl
For more information: https://t.co/XFH86z6Hi2

[PSR Orphan Experts (now Ergomed) @PSRorphan]

Today, in honor of #RareDiseaseDay, Ergomed offices have united around the world to raise global awareness for those impacted by rare diseases.

Watch our video below to see how we’ve supported virtually this year!

https://t.co/A9EkoN3HYC

[PSR Orphan Experts (now Ergomed) @PSRorphan]

Did you know that there are over 300 million people living with a Rare Disease? All of us make the #pledge4rare to raise global awareness for those impacted by a rare disease. Join us today!

[Ergomed @ErgomedPLC]

We are pleased to be featured in Crosstree's in-depth guide to the most innovative companies in pharma services. Being recognized as industry experts alongside over 50 of the industry's top innovators is a great honor!
https://t.co/sjjk5cxjMN

[PrimeVigilance @PrimeVigilance]

Did you miss the latest PrimeVigilance free learning webinar with our experts Hyankova Jana & Marcela Fialova as they discussed the impact that Brexit has had on the EU and the UK pharmacovigilance processes? No worries, watch the recording right now! https://t.co/3uWh6iLCZv

[Ergomed @ErgomedPLC]

We’re looking for passionate and focused people to join our team; people who are inspired by the notion of improving patient lives.

Take a look at Snježana’s insight of her journey at Ergomed:
https://t.co/G9CVMkHjhz

[Ergomed @ErgomedPLC]

Why our clients choose the Ergomed Clinical Research Team to support their Oncology trials

Find out more about the uniqueness, flexibility, and resilience of Ergomed’s approach, tailored to your specific requirements. Please visit https://t.co/eOXByaz6R4

[PrimeVigilance @PrimeVigilance]

Sign up now for the free PrimeVigilance learning webinar titled "The Impact of Brexit on Pharmacovigilance," happening on 28 January.

To register: https://t.co/GEq44Syas3
For more information: https://t.co/AIAw6yALlQ

[Ergomed @ErgomedPLC]

Are you looking to kick-start and build your career in one of the most rewarding fields in the world? Watch our passionate employees talk about their work and why they chose Ergomed to develop and showcase their skills.
Watch Tonya’s Ergomed journey story: https://t.co/uR5n7mA2gt

[PrimeVigilance @PrimeVigilance]

NEWS: Please join us for our first 2021 free learning #webinar, which is open for registration with the topic "The Impact of Brexit on Pharmacovigilance".

To register https://t.co/KgthpmIvPW
For more information https://t.co/oy9mpc6aHJ

#pharmacovigilance #Brexit

[Ergomed @ErgomedPLC]

If you are looking to build your career in one of the most rewarding fields in the world, watch our passionate people talking about their work!
We’re looking for passionate and focused people who are inspired to improve patient lives to join us.
Marija: https://t.co/vi7X9DsPFo

[PSR Orphan Experts (now Ergomed) @PSRorphan]

Season's Greetings from all of us at PSR.
We would like to extend our very best wishes to everyone for the new year and to express our appreciation and gratitude to all our clients, colleagues, and partners.
We look forward to 2021!
#2021 #PatientSafety #CRO #SeasonsGreetings

[PSR Orphan Experts (now Ergomed) @PSRorphan]

News - As part of @ErgomedPLC, we are delighted to share the news about Ergomed's acquisition of @MedSourceCRO, a US CRO specialized in oncology and rare disease.

https://t.co/f0mKHQlOWL

#RareDisease #clinicalresearch

[PSR Orphan Experts (now Ergomed) @PSRorphan]

Latest @Pharmafile edition is featuring Ergomed Patient Engagement Officer, Bojana Mirosavljevic, and her inspiring story about her heartbreaking personal experience with a rare disease, and the importance of a patient-centric approach in clinical trials.
https://t.co/ylkQHcUhdK

[Ergomed @ErgomedPLC]

Ergomed's latest case study on the first non-interventional epidemiology study in NSCLC conducted in different countries, resulting in for the first time generation of important data on the prevalence of ALK gene rearrangement https://t.co/qJ0QX3cSM4

#NSCLC #oncologytrials #RWE

[Ergomed @ErgomedPLC]

@ErgomedPLC is delighted to welcome Dora Alvarado as Global Head of Human Resources. Dora brings to Ergomed over 20 years of expertise and knowledge of different HR operating models to deliver an HR service that will flex and adapt to our needs. Welcome to Ergomed Dora!